EIP Pharma Patents – Insights & Stats (Updated 2023)

EIP Pharma has a total of 47 patents globally, out of which 24 have been granted. Of these 47 patents, more than 65% patents are active. The USA is where EIP Pharma has filed the maximum number of patents, followed by Japan and China. Parallelly, the USA seems to be the main focused R&D center of EIP Pharma and is also the origin country of the firm.

EIP Pharma was founded in the year 2014 by John Alam and Sylvie Grégoire. EIP Pharma is a clinical-stage pharmaceuticals firm that specialises in the creation and marketing of medication therapies for neurodegenerative illnesses, with a focus on the early phases of the neurodegenerative process. The company’s medication helps patients with acute brain damage regain function.

Do read about some of the most popular patents of EIP Pharma which have been covered by us in this article and also you can find EIP Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over EIP Pharma patent portfolio.

How many patents does the founder and the CEO of EIP Pharma have?

The founders, John Alam (also CEO) and Sylvie Grégoire, have 0 patents.

How many patents does EIP Pharma have?

EIP Pharma has a total of 47 patents globally. These patents belong to 8 unique patent families. Out of 47 patents, 31 patents are active.

How Many Patents did EIP Pharma File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant EIP Pharma Applications Filed EIP Pharma Patents Granted
2022 1 5
2021 1
2020 4
2019 4 4
2018 3
2017 3 4
2016 7
2015 12 5
2014 3
2013 1
2012 14

How many EIP Pharma patents are Alive/Dead?

Worldwide Patents

How Many Patents did EIP Pharma File in Different Countries?

Where are Research Centres of EIP Pharma Patents Located?

10 Best EIP Pharma Patents

US9427439B1 is the most popular patent in the EIP Pharma portfolio. It has received 7 citations so far from companies like Fulcrum Therapeutics.

Below is the list of 10 most cited patents of EIP Pharma:

Publication Number Citation Count
US9427439B1 7
US9427438B2 6
US8697627B2 6
WO2017075013A1 5
US20140357638A1 4
CN106659723A 4
WO2017185073A1 4
US9579322B2 3
CN108348524A 3
WO2019056003A1 3

What are EIP Pharma key innovation segments?

What Technologies are Covered by EIP Pharma?

The chart below distributes patents filed by EIP Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where EIP Pharma thinks it’s important to protect particular technology inventions.

R&D Focus: How has EIP Pharma search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by EIP Pharma?

Was this article helpful?

Leave a Comment

Table of Content

Popular Topics

Insights you may find interesting